Other species have very fragile embryos, or such a short spawning season that the window for delivering CRISPR-Cas9 into their eggs is exasperatingly brief. Doing so by microinjection ends up ...

Since the mid-2010s, when biotech companies first began commercializing CRISPR-Cas9, historic milestones after historic milestones have flown by. Patents have been granted. Regulatory approvals have ...